Amalgamated Bank’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,434
Closed -$11K 2364
2025
Q4
$11K Sell
3,434
-437
-11% -$1.47K ﹤0.01% 2383
2025
Q3
$11K Hold
3,871
﹤0.01% 2424
2025
Q2
$9K Hold
3,871
﹤0.01% 2489
2025
Q1
$9K Hold
3,871
﹤0.01% 2432
2024
Q4
$21K Hold
3,871
﹤0.01% 2100
2024
Q3
$32K Hold
3,871
﹤0.01% 1978
2024
Q2
$28K Sell
3,871
-17,967
-82% -$155K ﹤0.01% 2008
2024
Q1
$189K Buy
21,838
+2,229
+11% +$15.1K ﹤0.01% 1612
2023
Q4
$128K Sell
19,609
-1,270
-6% -$8.21K ﹤0.01% 1926
2023
Q3
$209K Sell
20,879
-58
-0.3% -$637 ﹤0.01% 1771
2023
Q2
$260K Sell
20,937
-1,877
-8% -$25.3K ﹤0.01% 1717
2023
Q1
$320K Sell
22,814
-7,060
-24% -$101K ﹤0.01% 1617
2022
Q4
$427K Buy
29,874
+5,050
+20% +$79.5K ﹤0.01% 1533
2022
Q3
$634K Buy
24,824
+250
+1% +$6.27K 0.01% 1318
2022
Q2
$698K Sell
24,574
-753
-3% -$23.9K 0.01% 1304
2022
Q1
$893K Buy
25,327
+2,431
+11% +$81.5K 0.01% 1256
2021
Q4
$959K Buy
22,896
+2,845
+14% +$115K 0.01% 1253
2021
Q3
$984K Buy
20,051
+3,848
+24% +$188K 0.01% 1250
2021
Q2
$676K Buy
16,203
+4,976
+44% +$193K 0.01% 1473
2021
Q1
$400K Buy
+11,227
New +$372K 0.02% 1103

Other funds holding MRVI

Amalgamated Bank's MRVI Position: Q1 2026 in Review

Amalgamated Bank sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 3,434 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in MRVI in Q1 2021 and held it in 20 quarters. The position peaked at $984K in Q3 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Amalgamated Bank reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,434 Maravai LifeSciences shares in Q1 2026, an estimated $11K.
  • Amalgamated Bank first reported a position in Maravai LifeSciences in Q1 2021 and held it in 20 quarters.
  • Amalgamated Bank's Maravai LifeSciences position peaked at $984K in Q3 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.